USD 31.16
(-2.53%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 23.22 Million USD | -0.43% |
2022 | 23.32 Million USD | -10.91% |
2021 | 26.17 Million USD | -8.08% |
2020 | 28.47 Million USD | -7.33% |
2019 | 30.73 Million USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | -100.0% |
2010 | 80.82 Thousand USD | -74.74% |
2009 | 320 Thousand USD | -77.33% |
2008 | 1.41 Million USD | -25.48% |
2007 | 1.89 Million USD | 568.54% |
2006 | 283.35 Thousand USD | -25.8% |
2005 | 381.87 Thousand USD | 613.24% |
2004 | 53.54 Thousand USD | 33.12% |
2003 | 40.21 Thousand USD | -62.74% |
2002 | 107.93 Thousand USD | -56.03% |
2001 | 245.5 Thousand USD | -51.38% |
2000 | 504.9 Thousand USD | -68.44% |
1999 | 1.6 Million USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 18.78 Million USD | -3.61% |
2024 Q3 | 17.94 Million USD | -4.45% |
2024 Q1 | 19.48 Million USD | -16.09% |
2023 FY | 23.22 Million USD | -0.43% |
2023 Q3 | 21.01 Million USD | -3.6% |
2023 Q2 | 21.8 Million USD | -3.42% |
2023 Q4 | 23.22 Million USD | 10.49% |
2023 Q1 | 22.57 Million USD | -3.21% |
2022 Q4 | 23.32 Million USD | -2.99% |
2022 Q2 | 24.77 Million USD | -2.84% |
2022 FY | 23.32 Million USD | -10.91% |
2022 Q1 | 25.49 Million USD | -2.61% |
2022 Q3 | 24.04 Million USD | -2.95% |
2021 FY | 26.17 Million USD | -8.08% |
2021 Q3 | 26.85 Million USD | -0.22% |
2021 Q4 | 26.17 Million USD | -2.51% |
2021 Q2 | 26.91 Million USD | -2.76% |
2021 Q1 | 27.67 Million USD | -2.82% |
2020 Q2 | 29.38 Million USD | -2.39% |
2020 FY | 28.47 Million USD | -7.33% |
2020 Q3 | 28.66 Million USD | -2.46% |
2020 Q1 | 30.1 Million USD | -2.03% |
2020 Q4 | 28.47 Million USD | -0.65% |
2019 Q2 | 32.04 Million USD | -1.06% |
2019 Q1 | 32.39 Million USD | 0.0% |
2019 FY | 30.73 Million USD | 0.0% |
2019 Q4 | 30.73 Million USD | -1.93% |
2019 Q3 | 31.33 Million USD | -2.21% |
2018 Q1 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q1 | 28 Million USD | 0.0% |
2015 Q2 | - USD | -100.0% |
2015 Q4 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2011 FY | - USD | -100.0% |
2011 Q4 | - USD | 0.0% |
2011 Q3 | - USD | -100.0% |
2011 Q2 | 477 Thousand USD | 17226.55% |
2011 Q1 | 2753.00 USD | -96.59% |
2010 Q3 | 200.07 Thousand USD | -26.75% |
2010 Q2 | 273.14 Thousand USD | 105.37% |
2010 Q1 | 133 Thousand USD | -80.18% |
2010 Q4 | 80.82 Thousand USD | -59.6% |
2010 FY | 80.82 Thousand USD | -74.74% |
2009 Q4 | 671 Thousand USD | 9.34% |
2009 Q2 | 867.37 Thousand USD | -22.42% |
2009 Q1 | 1.11 Million USD | -20.79% |
2009 FY | 320 Thousand USD | -77.33% |
2009 Q3 | 613.66 Thousand USD | -29.25% |
2008 Q2 | 1.45 Million USD | -12.79% |
2008 Q1 | 1.67 Million USD | -11.68% |
2008 Q3 | 1.25 Million USD | -13.78% |
2008 Q4 | 1.41 Million USD | 12.22% |
2008 FY | 1.41 Million USD | -25.48% |
2007 Q1 | 283.34 Thousand USD | -0.0% |
2007 Q4 | 1.89 Million USD | -9.87% |
2007 Q3 | 2.1 Million USD | -9.54% |
2007 Q2 | 2.32 Million USD | 719.97% |
2007 FY | 1.89 Million USD | 568.54% |
2006 FY | 283.35 Thousand USD | -25.8% |
2006 Q4 | 283.35 Thousand USD | -14.4% |
2006 Q3 | 331.02 Thousand USD | -13.07% |
2006 Q2 | 380.77 Thousand USD | 7.71% |
2006 Q1 | 353.52 Thousand USD | -7.43% |
2005 FY | 381.87 Thousand USD | 613.24% |
2005 Q2 | 338 Thousand USD | 118.69% |
2005 Q3 | 321.34 Thousand USD | -4.93% |
2005 Q4 | 381.87 Thousand USD | 18.84% |
2005 Q1 | 154.55 Thousand USD | 188.67% |
2004 FY | 53.54 Thousand USD | 33.12% |
2004 Q4 | 53.54 Thousand USD | -13.64% |
2004 Q3 | 62 Thousand USD | 494.5% |
2004 Q2 | 10.42 Thousand USD | -53.14% |
2004 Q1 | 22.25 Thousand USD | -44.66% |
2003 Q2 | 65.12 Thousand USD | -18.33% |
2003 Q1 | 79.74 Thousand USD | -26.12% |
2003 Q3 | 51.1 Thousand USD | -21.53% |
2003 Q4 | 40.21 Thousand USD | -21.3% |
2003 FY | 40.21 Thousand USD | -62.74% |
2002 Q2 | 161.37 Thousand USD | -17.36% |
2002 Q4 | 107.93 Thousand USD | -19.22% |
2002 FY | 107.93 Thousand USD | -56.03% |
2002 Q3 | 133.62 Thousand USD | -17.2% |
2002 Q1 | 195.27 Thousand USD | -20.46% |
2001 Q4 | 245.5 Thousand USD | -23.92% |
2001 Q1 | 420.87 Thousand USD | -16.64% |
2001 FY | 245.5 Thousand USD | -51.38% |
2001 Q3 | 322.67 Thousand USD | 2.48% |
2001 Q2 | 314.86 Thousand USD | -25.19% |
2000 FY | 504.9 Thousand USD | -68.44% |
2000 Q2 | 539.68 Thousand USD | -81.51% |
2000 Q1 | 2.91 Million USD | 0.0% |
2000 Q4 | 504.9 Thousand USD | -15.64% |
2000 Q3 | 598.53 Thousand USD | 10.91% |
1999 FY | 1.6 Million USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Inovalon Holdings, Inc. | 897.3 Million USD | 97.412% |
GE HealthCare Technologies Inc. | 9.86 Billion USD | 99.765% |
Sharecare, Inc. | 2.34 Million USD | -890.235% |
Progyny, Inc. | 19.39 Million USD | -19.758% |
Aclarion, Inc. | 1.12 Million USD | -1962.761% |
CareMax, Inc. | 491.93 Million USD | 95.28% |
Simulations Plus, Inc. | 475 Thousand USD | -4788.632% |
CareCloud, Inc. | 14.73 Million USD | -57.612% |
Forian Inc. | 23 Million USD | -0.953% |
Bullfrog AI Holdings, Inc. Warrants | - USD | -Infinity% |
Bullfrog AI Holdings, Inc. Common Stock | - USD | -Infinity% |
Minerva Surgical, Inc. | 39.69 Million USD | 41.494% |
Omnicell, Inc. | 614.09 Million USD | 96.219% |
Definitive Healthcare Corp. | 267.92 Million USD | 91.333% |
Zhongchao Inc. | 808.15 Thousand USD | -2773.331% |
Accolade, Inc. | 241.64 Million USD | 90.391% |
Streamline Health Solutions, Inc. | 10.56 Million USD | -119.771% |
Ontrak, Inc. | 1.68 Million USD | -1274.837% |
SOPHiA GENETICS SA | 18.6 Million USD | -24.837% |
R1 RCM Inc. | 1.74 Billion USD | 98.666% |
Spok Holdings, Inc. | 11.08 Million USD | -109.462% |
Privia Health Group, Inc. | 8.28 Million USD | -180.142% |
EUDA Health Holdings Limited | 3.37 Million USD | -588.126% |
HeartBeam, Inc. | - USD | -Infinity% |
GeneDx Holdings Corp. | 119.77 Million USD | 80.612% |
TruBridge, Inc. | 203.28 Million USD | 88.577% |
Nutex Health, Inc. | 275.75 Million USD | 91.579% |
Renalytix Plc | 8.53 Million USD | -172.068% |
Sharecare, Inc. | 2.34 Million USD | -890.235% |
Health Catalyst, Inc. | 249.06 Million USD | 90.677% |
10x Genomics, Inc. | 95.37 Million USD | 75.652% |
GoodRx Holdings, Inc. | 711.07 Million USD | 96.734% |
SCWorx Corp. | 90.35 Thousand USD | -25598.602% |
Schrödinger, Inc. | 127.88 Million USD | 81.842% |
HealthEquity, Inc. | 933.14 Million USD | 97.512% |
MSP Recovery, Inc. | 679.32 Million USD | 96.582% |
Augmedix, Inc. | 25.84 Million USD | 10.156% |
BrightSpring Health Services, Inc. Common Stock | 3.67 Billion USD | 99.367% |
Ontrak, Inc. | 1.68 Million USD | -1274.837% |
SHL Telemedicine Ltd. | 19.85 Million USD | -16.976% |
CareCloud, Inc. | 14.73 Million USD | -57.612% |
Premier, Inc. | 126 Million USD | 81.571% |
Certara, Inc. | 298.19 Million USD | 92.213% |
GeneDx Holdings Corp. | 119.77 Million USD | 80.612% |
OneMedNet Corporation | 5.1 Million USD | -355.196% |
BrightSpring Health Services, Inc. Tangible Equity Unit | 3.67 Billion USD | 99.367% |
EUDA Health Holdings Limited | 3.37 Million USD | -588.126% |
HeartBeam, Inc. | - USD | -Infinity% |
CareCloud, Inc. | 14.73 Million USD | -57.612% |
Mangoceuticals, Inc. | 128.67 Thousand USD | -17945.82% |
CareMax, Inc. | 491.93 Million USD | 95.28% |
Healthcare Triangle, Inc. | 4.31 Million USD | -437.897% |
National Research Corporation | 38.95 Million USD | 40.392% |
Aclarion, Inc. | 1.12 Million USD | -1962.761% |
OptimizeRx Corporation | 36.82 Million USD | 36.94% |